133 related articles for article (PubMed ID: 11960724)
21. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
22. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
23. Study of the in vivo and in vitro photosensitizing capabilities of uroporphyrin I compared to photofrin II.
Nelson JS; Sun CH; Berns MW
Lasers Surg Med; 1986; 6(2):131-6. PubMed ID: 2941630
[TBL] [Abstract][Full Text] [Related]
24. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication.
Nelson JS; Liaw LH; Lahlum RA; Cooper PL; Berns MW
J Natl Cancer Inst; 1990 May; 82(10):868-73. PubMed ID: 2139704
[TBL] [Abstract][Full Text] [Related]
25. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
26. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system.
Kostenich G; Orenstein A; Roitman L; Malik Z; Ehrenberg B
J Photochem Photobiol B; 1997 May; 39(1):36-42. PubMed ID: 9210320
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
Chang CJ; Yu JS; Wei FC
Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.
Banfi S; Caruso E; Caprioli S; Mazzagatti L; Canti G; Ravizza R; Gariboldi M; Monti E
Bioorg Med Chem; 2004 Sep; 12(18):4853-60. PubMed ID: 15336264
[TBL] [Abstract][Full Text] [Related]
29. Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer.
Igarashi A; Konno H; Tanaka T; Nakamura S; Sadzuka Y; Hirano T; Fujise Y
Toxicol Lett; 2003 Nov; 145(2):133-41. PubMed ID: 14581165
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer.
Abulafi AM; DeJode ML; Allardice JT; Ansell JK; Williams NS
Br J Surg; 1997 Mar; 84(3):368-71. PubMed ID: 9117310
[TBL] [Abstract][Full Text] [Related]
31. Biodistribution of haematoporphyrin analogues in a lung carcinoma model.
Tronconi M; Colombo A; De Cesare M; Marchesini R; Woodburn KW; Reiss JA; Phillips DR; Zunino F
Cancer Lett; 1995 Jan; 88(1):41-8. PubMed ID: 7850772
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of fluorescent polyporphyrin Photofrin II in normal rat tissue and rat bladder tumor.
Baumgartner R; Fuchs N; Jocham D; Stepp H; Unsöld E
Photochem Photobiol; 1992 Apr; 55(4):569-74. PubMed ID: 1535712
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy of photofrin II and excimer dye laser on experimental tumors.
Tanaka M; Uchibayashi T; Obata T; Sasaki T
Cancer Lett; 1995 Apr; 90(2):163-9. PubMed ID: 7736452
[TBL] [Abstract][Full Text] [Related]
34. A preliminary pharmacokinetic study of intravenous Photofrin in patients.
Bellnier DA; Dougherty TJ
J Clin Laser Med Surg; 1996 Oct; 14(5):311-4. PubMed ID: 9612197
[TBL] [Abstract][Full Text] [Related]
35. Effect of porphyrins on the hematopoietic recovery of mice treated with gamma-radiation.
Hunt DW; Sorrenti RA; Renke ME; Xie LY; Waterfield EM; Levy JG
Immunopharmacol Immunotoxicol; 1994 Feb; 16(1):55-70. PubMed ID: 8169323
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
37. Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin.
Rousset N; Vonarx V; Eléouet S; Carré J; Bourré L; Lajat Y; Patrice T
Res Exp Med (Berl); 2000 Jun; 199(6):341-57. PubMed ID: 10945652
[TBL] [Abstract][Full Text] [Related]
38. Porphyrins as radiosensitizing agents for solid neoplasms.
Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Hofstetter A; Dühmke E; Jori G
Curr Pharm Des; 2003; 9(25):2024-35. PubMed ID: 14529413
[TBL] [Abstract][Full Text] [Related]
39. Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo.
Morlière P; Mazière JC; Santus R; Smith CD; Prinsep MR; Stobbe CC; Fenning MC; Golberg JL; Chapman JD
Cancer Res; 1998 Aug; 58(16):3571-8. PubMed ID: 9721863
[TBL] [Abstract][Full Text] [Related]
40. Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of Photofrin II and TPPS.
West CM; Moore JV
Int J Radiat Biol; 1988 Oct; 54(4):621-34. PubMed ID: 2902160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
